On August 12, billionaire Peter Thiel once again positioned himself in Ethereum, according to the latest SEC filing, Peter Thiel and his investment team acquired 7.5% of the shares in ETHZilla, an Ethereum treasury reserve company (formerly 180 Life Sciences Corp.).
180 Life Sciences (stock code: ATNF) closed up over 11% on Monday and soared about 57% in after-hours trading. The company announced its Ethereum vault plan at the end of July. On Monday, this biotech company stated that it had sold $156 million of senior secured convertible notes due in 2028 to an institutional investor, following a $425 million private placement. The raised funds will be primarily used to purchase Ethereum, yield-generating assets, and the company's online gambling (iGaming) business, while monetizing its existing biotech intellectual property.
BlockBeats previously reported that on July 16, Peter Thiel's Founders Fund Growth II Management disclosed in an SEC filing on Tuesday evening that it held 9.1% of shares in BitMine Immersion Technologies as of July 8.
